U.S. Preventive Services Task Force banner
U.S. Preventive Services Task Force

You Are Here: U.S. Preventive Services Task Force > Draft Research Plan

 


DRAFT
 
DRAFT
 
DRAFT
 
DRAFT
 
DRAFT
 
DRAFT
 
DRAFT
 
DRAFT
 
DRAFT
 
DRAFT
 
DRAFT
 
DRAFT

Draft Research Plan

Screening for Syphilis Infection in Nonpregnant Adolescents and Adults


Note: This is a draft Research Plan. This draft is distributed solely for the purpose of receiving public input. It has not been disseminated otherwise by the USPSTF.

The final Research Plan will be used to guide a systematic review of the evidence by researchers at an Evidence-based Practice Center. The resulting Evidence Report will form the basis of the USPSTF Recommendation Statement on this topic.

This draft Research Plan is available for comment from June 26 to July 23, 2014, at 5:00 p.m., ET. You may wish to read the entire Research Plan before you comment.


I. Proposed Analytic Framework

Select Text Description below for details.

[D] Select for Text Description.

II. Proposed Key Questions to Be Systematically Reviewed

  1. What is the effectiveness of screening for syphilis infection in asymptomatic, nonpregnant, sexually active adolescents and adults to reduce complications of syphilis and transmission or acquisition of sexually transmitted infections (including the effectiveness of specific screening intervals and screening in population subgroups)?
  2. What is the effectiveness of risk assessment instruments or other risk stratification methods to identify individuals at increased risk for syphilis infection?
  3. What is the accuracy of currently used screening tests and testing strategies (e.g., sequence of tests) to detect syphilis infection?
  4. What are the harms of screening (e.g., labeling and false-positive and false-negative results)?

III. Proposed Contextual Question

Contextual questions will not be systematically reviewed and are not shown in the Analytic Framework.

  1. Which subgroups, including men who have sex with men, are at highest risk for incident syphilis infection? Which groups are at highest risk for morbidity and mortality due to syphilis infection?

IV. Proposed Research Approach

The Proposed Research Approach identifies the study characteristics and criteria that the Evidence-based Practice Center will use to search for publications and to determine whether identified studies should be included or excluded from the Evidence Report. Criteria are overarching as well as specific to each of the key questions (KQs).

  Include Exclude
Disease definition Positive result for syphilis on any test modality  
Populations Asymptomatic, nonpregnant adolescents and adults, including patients coinfected with other STIs (including HIV) Symptomatic patients; children; pregnant women; studies of HIV patients for whom syphilis testing is a disease management intervention rather than a screening intervention
Interventions KQs 1, 4: Screening effectiveness, including effectiveness of different screening intervals

KQ 2: Risk assessment instruments and other risk stratification methods that identify individuals at increased risk for syphilis infection

KQ 3: FDA-cleared tests available in the U.S. that detect syphilis in biological specimens, including varying testing strategies (e.g., traditional, reverse sequence)

 
Comparators KQ 1, 4: No screening or alternate screening strategy or methods

KQ 2: True disease status

KQ 3: Gold standard

No comparison
Outcomes KQ 1: Reduction in complications of syphilis (e.g., neurosyphilis), disease transmission, other clinical outcomes, and rates of infection and other similar measures of infection

KQ 2: Detection of infection

KQ 3: Diagnostic accuracy

KQ 4: Harms from screening (e.g., labeling and false-negative and false-positive results and their harms, including psychosocial harms)

KQ 1: Outcomes that are not directly related to health outcomes (e.g., laboratory studies)

KQ 4: Harms related to true positive and true negative tests, including psychosocial harms

Settings Primary care settings and primary care–referable settings (e.g., correctional settings and community care, such as schools and STI clinics)  
Study designs Good-quality systematic reviews

Benefits (KQs 1, 2, 3): RCTs; observational studies with comparison groups, including ecological studies

Harms (KQ 4): RCTs; observational studies, including cross-sectional studies and ecological studies

Benefits (KQs 1, 2, 3): Observational studies without comparison groups; case reports

Harms (KQ 4): Case studies

Abbreviations: FDA = U.S. Food and Drug Administration; HIV = human immunodeficiency virus; RCT = randomized, controlled trial; STI = sexually transmitted infection; U.S. = United States.

AHRQ Publication No. 14-05213-EF-5
Current as of June 2014


Internet Citation:

U.S. Preventive Services Task Force. Screening for Syphilis Infection in Nonpregnant Adolescents and Adults: Draft Research Plan. AHRQ Publication No. 14-05213-EF-5. http://www.uspreventiveservicestaskforce.org/draftresplan.htm



USPSTF Program Office   540 Gaither Road, Rockville, MD 20850